
While it is known that febrile neutropenia is the most common reason for pediatric patients with cancer visiting the emergency department (ED), little had been known about the most common reasons for adult patients with cancer ending up in the ED.

Laura Joszt, MA, is the vice president of content for the managed care and pharmacy brands at MJH Life Sciences®, which includes The American Journal of Managed Care®, Managed Healthcare Executive®, Pharmacy Times®, and Drug Topics®. She has been with MJH Life Sciences since 2011.
Laura has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.

While it is known that febrile neutropenia is the most common reason for pediatric patients with cancer visiting the emergency department (ED), little had been known about the most common reasons for adult patients with cancer ending up in the ED.

Some Republicans are interested in attaching a repeal of the individual mandate to a tax bill, and interest from members of Congress on the impact of such a move prompted the Congressional Budget Office to publish a revised estimate of what would happen.

After the Maine Legislature passed legislation to expand Medicaid on 5 separate occasions and each time the bill was vetoed by the governor, the state's voters took the issue into their own hands this election day.

A recap of abstracts presented at The American College of Rheumatology’s 2017 Annual Meeting, including an analysis of data available in an electronic health records database and outcomes and cost effectiveness of sarilumab.

In a pair of interviews, experts discuss neutropenia resulting from treatment of metastatic breast cancer with CDK4/6 inhibitors.

The House of Representatives passed a bill to fund the Children's Health Insurance Program (CHIP) for the next 5 years, but a lack of Democratic support means the bill's future in the Senate is unclear.

During the final panel at the fall meeting of the ACO & Emerging Healthcare Delivery Coalition® in Nashville, Tennessee, panelists discussed the progress specialties have made in moving to value-based payment models, as well as the challenges facing the industry as a whole. The panel consisted of 3 individuals who provided perspectives from specific specialties, and 1 with an overall policy perspective.

There have been tremendous improvements in healthcare quality and performance measurements, but one area where more needs to be done is incorporating social risk factors into these measurements, said Shantanu Agrawal, MD, CEO and president of National Quality Forum.

A new viewpoint in JAMA has proposed a way to make it safe for undocumented immigrants to get care: sanctuary hospitals.

After a study reported that physicians who authored dermatology clinical guidelines didn't always fully disclose financial conflicts of interest, the American Academy of Dermatology urged the public to view the findings with caution.

History of neutropenia with methotrexate, concurrent treatment with synthetic disease-modifying antirheumatic drugs (sDMARDs), and tocilizumab were risk factors for developing neutropenia while on biologic DMARDs (bDMARDs), according to a study published in The Journal of Rheumatology.

After mentioning it for months, President Donald Trump has officially decided to stop paying the cost-sharing reduction subsidies that help insurers keep premiums down for lower-income Americans.

AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers-from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.

The shift of the healthcare industry to focus more on quality care and prevention of health issues before they arise has increased attention on an area outside of healthcare that needs to be addressed: social determinants of health.

Despite their large and growing reach, accountable care organizations (ACOs) are still learning how to manage their populations and are slowly accepting more financial risk, according to the results of the Annual ACO Survey from the National Association of ACOs and Leavitt Partners.

Excessively low levels of low-density lipoprotein cholesterol and triglycerides is associated with a higher all-cause mortality among American Indians, according to a new study published online ahead of print in Journal of Diabetes and Its Complications.

Bacteria in the gut may influence how effective cancer immunotherapies are, according to researchers at the Harold C. Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center.

Patients who feel they have little control over their health are more likely to report being depressed as a result of pain they experience. Targeting a patient’s sense of control can improve outcomes and remove barriers to recovery for patients with pain.

While the United States typically ranked first in rates of diagnosed conditions among 10 countries evaluated for patient insights into pressing health issues, it had the lowest work productivity impairment and activity impairment, according to a new report from Kantar Health.

While death rates from breast cancer declined 39% from 1989 to 2015, there are clear racial differences with black women having higher breast cancer death rates than white women, according to a new report from the American Cancer Society.

Adults with moderate-to-severe atopic dermatitis who were treated with Dupixent (dupilumab) from Sanofi and Regeneron along with topical corticosteroids experienced improvements in overall disease severity, according to results from phase 3 of the CAFÉ trial.

The FDA has rejected an abuse-deterrent opioid citing the need for further evidence. Rexista, an Oxycodone Hydrochloride Extended-Release tablet (Oxycodone ER), was developed by Intellipharmaceutics International Inc as an abuse- and alcohol-deterrent controlled-release oral formulation of oxycodone hydrochloride for pain relief.

CMS has issued an informal request for information seeking input on a new direction promoting patient-centered care and market-driven reforms for the CMS Innovation Center.

Salt intake may be associated with an increased risk of developing diabetes. Research presented at the annual meeting of the European Association for the Study of Diabetes and published in Diabetologia found sodium intake increased the risk of developing both type 2 diabetes and latent autoimmune diabetes in adults.

In the wake of Hurricane Harvey, Houston is expected to face a host of health challenges, including air pollution. Here are 5 facts about how air pollution affects people’s health.

Recent advances in brain imaging have improved understanding of acute and chronic pain, but have led to an increased in the demand to use this data for insurance and medical legal cases. However, a task force is advising against the use of brain imaging as a “lie detector” test for chronic pain.

As the healthcare industry struggles to address rising costs and unaffordable care, attention is turning to value-based benefit design options. Altarum has released its outline for a new value-based insurance design model that it will test at pilot sites across the country.

As the healthcare industry struggles to address rising costs and unaffordable care, attention is turning to value-based benefit design options. Altarum has released its outline for a new value-based insurance design model that it will test at pilot sites across the country.

There may be a connection between sleep troubles and attention-deficit/hyperactivity disorder (ADHD), according to an expert at the 30th European College of Neuropsychopharmacology Congress, which was held September 2-5 in Paris, France.

Ohio Governor John Kasich and Colorado Governor John Hickenlooper sat together at an event co-hosted by the American Enterprise Institute and the Center for American Progress to discuss bipartisan consensus around health reform policies and their commitment to quality, not quantity, medicine.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
